PhD: Department of Gastroentrology, Hepatology and Infectious Diseases, University Hospital of Duesseldorf, Duessledorf, Germany, 2001
MS: Molecular Immunology, Department of Molecular Parasitology, University of Duesseldorf, Duesseldorf, Germany, 1996
BS: Molecular Biology, Department of Molecular Parasitology, University of Duesseldorf, Duesseldorf, Germany, 1992
Dr. Hassan received his PhD in Biomedical Science, University Hospital of Duesseldorf, in 2001. Dr. Hassan's primary research interest is the mechanisms regulating cancer stem cell progression, resistance and recurrence, with main focus on melanoma stem cells.
Our previous and current studies on melanoma stem cells revealed that melanoma progression, metastasis, resistance to standard, and recurrence are attributed to a significant alteration in the genetic and epigenetic profile of a small fraction of melanoma cells with stem cell properties. These melanoma subpopulations are characterized by their unique protein signature and excessive activation of tumor growth-driving signaling pathways. These characteristics of melanoma stem cells are either in a causal or consequential relationship to melanoma progression, metastasis, resistance and recurrence. Also, we will expand our findings in cancer stem cell research to other tumor types, particularly thyroid cancer with the aim to establish an innovative cancer stem cell program for this disease. As a member of an international team, whose research activity based in Germany, France and the USA, we welcome every active collaboration in the field of cancer stem cell research.
View Dr. Hassan's publications on PubMed